Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Transpek Industry Limited (TRANSPEK.BO)
INR966.60
-0.55 (-0.06%)
IN BSE Basic Materials Chemicals - Specialty
Address
Lilleria 1038
Vadodara, IN
Vadodara, IN
CEO
Bimal Vasantlal Mehta
Website
transpek.com
IPO
2024-12-30
ISIN INE687A01016
Description
Transpek Industry Ltd. specializes in producing and exporting a diverse range of chemical products, supplying them to key sectors such as the textile, pharmaceutical, agrochemical, and polymer industries. The company was established on October 6, 1965, and its corporate headquarters are situated in Vadodara, India.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
INR966.60
-0.55 (-0.06%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1.5K
Beta
0.12
Float Shares
2.00M
Free Float %
35.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.65% | -10.70% | -8.80% | +9.91% | -20.99% | -15.48% | -32.56% | -47.37% | -27.88% | +182.74% | +5,101.94% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
966.60
DCF (Unlevered)
1,286.60
+33.1%
DCF (Levered)
1,307.33
+35.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2025-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.56
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-4.4% Q1'26: -10.3% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-6.3% Q1'26: -65.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+2.8% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+7.2% Q1'26: +4.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.6% Q1'26: +2.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: -0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.80× ★ Q1'26: 1.05× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
Mar 2032 1 Rev. Ana. 1 EPS Ana. |
Mar 2033 1 Rev. Ana. 1 EPS Ana. |
Mar 2034 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.84B
est: 2.84B (0.0%)
|
3.17B
est: 3.19B (-0.7%)
|
3.61B
est: 3.70B (-2.7%)
|
5.94B
est: 5.95B (-0.2%)
|
5.65B
est: 7.08B (-20.2%)
|
3.39B
est: 8.35B (-59.5%)
|
5.98B
est: 6.06B (-1.3%)
|
8.26B
est: 7.43B (+11.1%)
|
5.79B
est: 8.53B (-32.1%)
|
3.19B
3.19B – 3.19B
-62.6% YoY
|
3.70B
3.70B – 3.70B
+16.3% YoY
|
5.95B
5.95B – 5.95B
+60.5% YoY
|
7.08B
7.08B – 7.08B
+19.0% YoY
|
8.35B
8.35B – 8.35B
+18.0% YoY
|
6.06B
6.06B – 6.06B
-27.4% YoY
|
7.43B
7.43B – 7.43B
+22.6% YoY
|
8.53B
8.53B – 8.53B
+14.7% YoY
|
| EBITDA |
481.32M
est: 527.57M (-8.8%)
|
601.40M
est: 592.56M (+1.5%)
|
525.49M
est: 688.90M (-23.7%)
|
1.32B
est: 1.11B (+19.3%)
|
1.35B
est: 1.32B (+2.8%)
|
644.52M
est: 1.55B (-58.5%)
|
1.25B
est: 1.13B (+10.4%)
|
1.65B
est: 1.38B (+19.4%)
|
1.07B
est: 1.59B (-32.2%)
|
592.56M
592.56M – 592.56M
-62.6% YoY
|
688.90M
688.90M – 688.90M
+16.3% YoY
|
1.11B
1.11B – 1.11B
+60.5% YoY
|
1.32B
1.32B – 1.32B
+19.0% YoY
|
1.55B
1.55B – 1.55B
+18.0% YoY
|
1.13B
1.13B – 1.13B
-27.4% YoY
|
1.38B
1.38B – 1.38B
+22.6% YoY
|
1.59B
1.59B – 1.59B
+14.7% YoY
|
| EBIT |
396.39M
est: 348.39M (+13.8%)
|
496.26M
est: 391.31M (+26.8%)
|
443.24M
est: 454.93M (-2.6%)
|
1.17B
est: 730.13M (+60.7%)
|
1.06B
est: 868.85M (+22.5%)
|
359.46M
est: 1.03B (-64.9%)
|
947.80M
est: 744.66M (+27.3%)
|
1.32B
est: 912.89M (+44.6%)
|
698.67M
est: 1.05B (-33.3%)
|
391.31M
391.31M – 391.31M
-62.6% YoY
|
454.93M
454.93M – 454.93M
+16.3% YoY
|
730.13M
730.13M – 730.13M
+60.5% YoY
|
868.85M
868.85M – 868.85M
+19.0% YoY
|
1.03B
1.03B – 1.03B
+18.0% YoY
|
744.66M
744.66M – 744.66M
-27.4% YoY
|
912.89M
912.89M – 912.89M
+22.6% YoY
|
1.05B
1.05B – 1.05B
+14.7% YoY
|
| Net Income |
212.78M
est: 202.49M (+5.1%)
|
299.76M
est: 260.75M (+15.0%)
|
264.03M
est: 313.49M (-15.8%)
|
657.37M
est: 656.91M (+0.1%)
|
729.42M
est: 829.86M (-12.1%)
|
233.12M
est: 983.81M (-76.3%)
|
654.01M
est: 659.71M (-0.9%)
|
834.77M
est: 915.55M (-8.8%)
|
385.59M
est: 1.12B (-65.6%)
|
260.75M
260.75M – 260.75M
-76.7% YoY
|
313.49M
313.49M – 313.49M
+20.2% YoY
|
656.91M
656.91M – 656.91M
+109.6% YoY
|
829.86M
829.86M – 829.86M
+26.3% YoY
|
983.81M
983.81M – 983.81M
+18.6% YoY
|
659.71M
659.71M – 659.71M
-32.9% YoY
|
915.55M
915.55M – 915.55M
+38.8% YoY
|
1.12B
1.12B – 1.12B
+22.3% YoY
|
| SGA |
63.77M
est: 286.51M (-77.7%)
|
223.11M
est: 321.80M (-30.7%)
|
276.32M
est: 374.12M (-26.1%)
|
450.29M
est: 600.43M (-25.0%)
|
490.93M
est: 714.52M (-31.3%)
|
451.63M
est: 843.13M (-46.4%)
|
517.19M
est: 612.38M (-15.5%)
|
612.97M
est: 750.73M (-18.4%)
|
626.85M
est: 861.01M (-27.2%)
|
321.80M
321.80M – 321.80M
-62.6% YoY
|
374.12M
374.12M – 374.12M
+16.3% YoY
|
600.43M
600.43M – 600.43M
+60.5% YoY
|
714.52M
714.52M – 714.52M
+19.0% YoY
|
843.13M
843.13M – 843.13M
+18.0% YoY
|
612.38M
612.38M – 612.38M
-27.4% YoY
|
750.73M
750.73M – 750.73M
+22.6% YoY
|
861.01M
861.01M – 861.01M
+14.7% YoY
|
| EPS |
36.24
est: 36.25 (0.0%)
|
51.89
est: 46.68 (+11.2%)
|
47.27
est: 56.12 (-15.8%)
|
117.69
est: 117.60 (+0.1%)
|
130.59
est: 148.56 (-12.1%)
|
41.74
est: 176.12 (-76.3%)
|
117.09
est: 118.10 (-0.9%)
|
149.45
est: 163.90 (-8.8%)
|
69.03
est: 200.40 (-65.6%)
|
46.68
46.68 – 46.68
-76.7% YoY
|
56.12
56.12 – 56.12
+20.2% YoY
|
117.60
117.60 – 117.60
+109.6% YoY
|
148.56
148.56 – 148.56
+26.3% YoY
|
176.12
176.12 – 176.12
+18.6% YoY
|
118.10
118.10 – 118.10
-32.9% YoY
|
163.90
163.90 – 163.90
+38.8% YoY
|
200.40
200.40 – 200.40
+22.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-26 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
468.28M
OE per share TTM
83.80
Owner's Yield
7.82%
Maintenance CapEx ratio
8.60%
Maint CapEx / Avg PPE
56.5%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
771.5K
Shares Outstanding
5.59M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bimal Vasantlal Mehta | MD & Director | 43M | male |
| Avtar Singh | Joint MD & Whole-Time Director | 33M | male |
| Gurpreet S. Kaur | Senior General Manager of R&D, QC & QM | — | — |
| Hemant Shah | Senior General Manager of Operations | — | male |
| Prashant Vaidya | Vice President of HRM | — | male |
| Pratik Prakash Shah | Vice President of Finance & Chief Financial Officer | — | male |
| Sharad R. Patil | Vice President of Marketing | — | male |
| Alak Deepak Vyas | Senior Manager, Company Secretary & Compliance Officer | — | male |
| Vipul Parikh | Senior General Manager of Engineering Services | — | — |
| Ashish Pathak | Vice President of Strategy & Business Development | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TRANSPEK.BO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
